Found 6 matching trials
Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab
N/AhMe-Seal is a low-input whole-genome cell-free 5hmC sequencing method based...
Location
Peking University People's Hospital
Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis
N/APatients with peritoneal metastasis of colorectal or high grade appendiceal...
Status
Active Not Recruiting
Location
The University of Chicago
cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer
N/AThe EpiCORE study aims to identify cfDNA-based epigenetic markers predictiv...
Location
City of Hope Medical Center
Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker
PHASE2This is a therapeutic intervention trial evaluating the clinical utility of...
Location
Houston Methodist Neal Cancer Center
Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC
N/AThe EpiDRIVE study aims to identify cfDNA-based epigenetic determinants of ...
Location
City of Hope Medical Center
Epigenetic Signature for CRC Early Detection
N/AThe epiCED is a noninvasive blood-based assay designed for early detection ...
Status
Active Not Recruiting
Location
City of Hope Nat Medical Ctr